These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9650432

  • 21. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B.
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [Abstract] [Full Text] [Related]

  • 22. Malignancy in renal recipients.
    Samhan M, Al-Mousawi M, Donia F, Fathi T, Nasim J, Nampoory MR.
    Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307
    [Abstract] [Full Text] [Related]

  • 23. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD, Angele MK, Schwarz B, Pratschke S, Rentsch M, Khandoga A, Guba M, Jauch KW, Bruns C, Graeb C.
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [Abstract] [Full Text] [Related]

  • 24. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
    Rogers A, Ng JK, Glendinning J, Rix D.
    BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
    [Abstract] [Full Text] [Related]

  • 25. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.
    Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, Jauch KW, Guba M.
    Kidney Int; 2007 Jun; 71(12):1271-8. PubMed ID: 17332737
    [Abstract] [Full Text] [Related]

  • 26. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
    Einollahi B, Nemati E, Lessan-Pezeshki M, Simforoosh N, Nourbala MH, Rostami Z, Nafar M, Pourfarziani V, Beiraghdar F, Mahdavi-Mazdeh M, Ahmadpour P, Makhdoomi K, Ghafari A, Ardalan MR, Taebi Khosroshahi H, Oliaei F, Shahidi S, Makhlogh A, Azmandian J, Samimagham HR, Shabazian H.
    Ann Transplant; 2010 Jun; 15(3):44-50. PubMed ID: 20877266
    [Abstract] [Full Text] [Related]

  • 27. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
    Akbarzadehpasha A, Oliaei F, Asrari MR, Alizadeh-Navaei R.
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1044-7. PubMed ID: 21060171
    [Abstract] [Full Text] [Related]

  • 28. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients.
    Hsu RB, Chang CI, Tsai MK, Lee PH, Chou NK, Chi NH, Wang SS, Chu SH.
    Eur J Cardiothorac Surg; 2010 May; 37(5):1117-21. PubMed ID: 20045346
    [Abstract] [Full Text] [Related]

  • 29. Transitional cell carcinoma in renal transplant recipients: a single center experience.
    Li XB, Xing NZ, Wang Y, Hu XP, Yin H, Zhang XD.
    Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
    [Abstract] [Full Text] [Related]

  • 30. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.
    Hibberd AD, Trevillian PR, Wlodarczyk JH, Kemp DG, Stein AM, Gillies AH, Heer MK, Sheil AG.
    Transplantation; 2013 Jan 15; 95(1):122-7. PubMed ID: 23238532
    [Abstract] [Full Text] [Related]

  • 31. Malignancy in renal transplant recipients: a single-center experience in Thailand.
    Ruangkanchanasetr P, Lauhawatana B, Leawseng S, Kitpanich S, Lumpaopong A, Thirakhupt P.
    J Med Assoc Thai; 2012 May 15; 95 Suppl 5():S12-6. PubMed ID: 22934439
    [Abstract] [Full Text] [Related]

  • 32. Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.
    Koukourgianni F, Harambat J, Ranchin B, Euvrard S, Bouvier R, Liutkus A, Cochat P.
    Nephrol Dial Transplant; 2010 Feb 15; 25(2):611-6. PubMed ID: 19820249
    [Abstract] [Full Text] [Related]

  • 33. Urological malignancy after renal transplantation.
    Besarani D, Cranston D.
    BJU Int; 2007 Sep 15; 100(3):502-5. PubMed ID: 17669141
    [Abstract] [Full Text] [Related]

  • 34. [Early de novo neoplasia after renal transplantation].
    Veroux P, Veroux M, Puliatti C, Amodeo C, Macarone M, Cappello D, Caglià P.
    Tumori; 2003 Sep 15; 89(4 Suppl):301-4. PubMed ID: 12903627
    [Abstract] [Full Text] [Related]

  • 35. Post-transplant de novo malignancies in renal transplant recipients: the past and present.
    Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW.
    Transpl Int; 2006 Aug 15; 19(8):607-20. PubMed ID: 16827677
    [Abstract] [Full Text] [Related]

  • 36. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y, Lay F, Luccioni A, Daniel L, Berland Y, Coulange C, Lechevallier E.
    Cancer; 2005 Jan 15; 103(2):251-7. PubMed ID: 15593084
    [Abstract] [Full Text] [Related]

  • 37. Malignancies after kidney transplantation: a 40-year single-center experience in Korea.
    Hwang JK, Moon IS, Kim JI.
    Transpl Int; 2011 Jul 15; 24(7):716-21. PubMed ID: 21575081
    [Abstract] [Full Text] [Related]

  • 38. The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy.
    Klintmalm GB, Saab S, Hong JC, Nashan B.
    Clin Transplant; 2014 Jun 15; 28(6):635-48. PubMed ID: 24628264
    [Abstract] [Full Text] [Related]

  • 39. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J.
    Liver Transpl; 2002 May 15; 8(5):482-7. PubMed ID: 12004349
    [Abstract] [Full Text] [Related]

  • 40. De novo malignancy is associated with renal transplant tourism.
    Tsai MK, Yang CY, Lee CY, Yeh CC, Hu RH, Lee PH.
    Kidney Int; 2011 Apr 15; 79(8):908-13. PubMed ID: 21270768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.